Protein phosphatase 5 (PP5) is an evolutionary conserved serine/threonine phosphatase. Its dephosphorylation activity modulates a diverse set of cellular factors including protein kinases and the microtubule-associated tau protein involved in neurodegenerative disorders. It is auto-regulated by its heat-shock protein (Hsp90)-interacting tetratricopeptide repeat (TPR) domain and its C-terminal α-helix. In the present study, we report the identification of five specific PP5 activators [PP5 small-molecule activators (P5SAs)] that enhance the phosphatase activity up to 8-fold. The compounds are allosteric modulators accelerating efficiently the turnover rate of PP5, but do barely affect substrate binding or the interaction between PP5 and the chaperone Hsp90. Enzymatic studies imply that the compounds bind to the phosphatase domain of PP5. For the most promising compound crystallographic comparisons of the apo PP5 and the PP5-P5SA-2 complex indicate a relaxation of the auto-inhibited state of PP5. Residual electron density and mutation analyses in PP5 suggest activator binding to a pocket in the phosphatase/TPR domain interface, which may exert regulatory functions. These compounds thus may expose regulatory mechanisms in the PP5 enzyme and serve to develop optimized activators based on these scaffolds.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4721540PMC
http://dx.doi.org/10.1042/BSR20150042DOI Listing

Publication Analysis

Top Keywords

pp5
9
protein phosphatase
8
protein
5
phosphatase
5
selective activators
4
activators protein
4
phosphatase target
4
target auto-inhibitory
4
auto-inhibitory mechanism
4
mechanism protein
4

Similar Publications

Detection of a novel DNA methylation marker panel for esophageal cancer diagnosis using circulating tumor DNA.

BMC Cancer

December 2024

Department of Molecular Pathology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, No 127, Dongming Road, Zhengzhou, 450008, Henan, China.

Background: Esophageal cancer (ECa) is one of the most deadly cancers, with increasing incidence worldwide and poor prognosis. While endoscopy is recommended for the detection of ECa in high-risk individuals, it is not suitable for large-scale screening due to its invasiveness and inconvenience.

Methods: In this study, a novel gene methylation panel was developed for a blood-based test, and its diagnostic efficacy was evaluated using a cohort of 304 participants (203 cases, 101 controls).

View Article and Find Full Text PDF

TFPI2 hypermethylation promotes diabetic atherosclerosis progression through the Ap2α/PPARγ axis.

J Mol Cell Cardiol

December 2024

Department of Cardiology, The Affiliated Hospital of Qingdao University, 16 Jiangsu Road, Qingdao 266003, Shandong, China. Electronic address:

Article Synopsis
  • - Diabetes significantly increases the risk of atherosclerosis, causing serious cardiovascular problems, with research showing that the protein TFPI2 is expressed at lower levels in atherosclerotic plaques of diabetic patients.
  • - Experiments demonstrated that knocking down TFPI2 in non-diabetic mice led to more severe plaque buildup and increased inflammation, while boosting TFPI2 in diabetic mice improved plaque stability and promoted beneficial M2 macrophage activity.
  • - The study reveals that the interaction between TFPI2 and a transcription factor called AP-2α is essential for regulating inflammation and plaque stability in diabetes, suggesting that targeting this pathway could be a novel way to treat diabetes-related cardiovascular diseases.
View Article and Find Full Text PDF

Hypothermic oxygenated perfusion inhibits CLIP1-mediated TIRAP ubiquitination via TFPI2 to reduce ischemia‒reperfusion injury of the fatty liver.

Exp Mol Med

December 2024

Zhongnan Hospital of Wuhan University, Institute of Hepatobiliary Diseases of Wuhan University, Transplant Center of Wuhan University, National Quality Control Center for Donated Organ Procurement, Hubei Key Laboratory of Medical Technology on Transplantation, Hubei Clinical Research Center for Natural Polymer Biological Liver, Hubei Engineering Center of Natural Polymer-based Medical Materials, 430071, Wuhan, China.

The use of fatty livers in liver transplantation has emerged as a crucial strategy to expand the pool of donor livers; however, fatty livers are more sensitive to ischemia‒reperfusion injury (IRI). Excessive congenital inflammatory responses are crucial in IRI. Hypothermic oxygenated perfusion (HOPE) is a novel organ preservation technique that may improve marginal donor liver quality by reducing the inflammatory response.

View Article and Find Full Text PDF

Enhanced radiotherapy susceptibility in NSCLC through palbociclib-mediated PP5 inhibition.

Biochim Biophys Acta Mol Cell Res

November 2024

Department of Biotechnology and Laboratory Science in Medicine, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan. Electronic address:

Article Synopsis
  • * Our study found that the protein PP5 is more highly expressed in NSCLC tissues than in normal tissues, and high levels of PP5 are linked to worse survival rates, especially in patients receiving radiotherapy.
  • * We demonstrated that the drug palbociclib targets PP5 and improves the effectiveness of radiotherapy by causing DNA damage and activating AMPK, leading to cell death; these findings suggest that targeting PP5 could be a promising strategy for overcoming radioresistance in NSCLC.
View Article and Find Full Text PDF

Renal and ovarian clear cell carcinoma (CCC) are both characterized by a clear cytoplasm and exhibit similar genomic alterations and clinical characteristics. We hypothesized that both CCCs may share clinical biomarker. Tissue factor pathway inhibitor 2 (TFPI2), a serine protease inhibitor, has emerged as a promising serum biomarker for ovarian CCC, and we evaluated the efficacy of TFPI2 as a biomarker for renal cell carcinoma (RCC).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!